Page 1 of 1 Proteomics International Media Release May 24, 2010
MEDIA RELEASE
May 24th, 2010
Proteomics International expands its contract research services in Asia
Proteomics International expands its ISO accredited contract research services to
other key Asian countries announcing that they have signed an exclusive agreement
with Singapore based company 1st BASE to act as their agent to deliver a range of
proteomics based contract research services in Singapore, Malaysia Indonesia and
Thailand.
The company will work with 1st BASE to promote delivery of quality analytical services for
biological research and development for pharmaceutical, biotechnology, academic and
Government organisations. Proteomics International has a wealth of expertise in
protein/peptide chemistry and can provide an array of proteomic and mass spectrometry
services that are uniquely accredited (ISO/IEC 17025).
1st BASE is a leading life sciences products manufacturer and custom service provider. They
have been in operation for more than 7 years and have been serving the research community in the
Asia pacific region with a comprehensive range of customized products and services. Proteomics
International will benefit from the strength of 1st BASE in this region.
Dr. Richard Lipscombe from the privately owned, Australian based company Proteomics International
commented, “We are delighted to be working with 1st BASE as it is an exciting step to significantly
expanding our existing blue chip client base, primarily located in India and Australia. Accredited and
highly affordable protein analysis and characterisation services are routinely offered and many clients
ask us to also deliver advanced consultancy to assist with their product development requirements.
Our growing team of highly qualified protein scientists, combined with the most advanced mass
spectrometry instrumentation and in-house proteomics computing power are readily available to
process samples that can be quickly and easily sent to us or we can provide consultation for your
complex biological system and protein based challenges.”
About Proteomics International Pty Ltd
Proteomics International is both a contract service provider and research and development company,
focused on providing quality analytical services to the biological research market and on developing
value from protein drug discovery. Proteomics International is the world's first ISO/IEC 17025
accredited proteomics services laboratory, and combines the most advanced high throughput mass
spectrometry instrumentation (MALDI TOF-TOF and LC-MS/MS) and a team of qualified scientists
with proven expertise in protein and peptide chemistry. The company has two focal research
activities; analysis of venoms using its proprietary Bioven process, and the discovery and use of
biomarkers from a variety of tissue sources. Skills developed from these research programs are
incorporated into the sophisticated suite of specialist contract research techniques provided to clients
such as iTRAQ, MRM, and de novo proteome mapping. High quality, fast and affordable protein
identification, analytical and characterisation services are routinely provided to support all
peptide/protein requirements including biosimilar and protein drug development programs.
Proteomics International is based in Perth, Western Australia and has established itself as an industry
leader in the delivery of contract research and lead molecule discovery services in the Asia Pacific
region. Proteomics
International is actively seeking distributors and collaboration partners
from many countries.
For more information contact:
Mr Barry Epstein - VP Marketing
Telephone +61 8 9389 1992
Facsimile +61 8 9389 1981
Email barry@proteomics.com.au
NEWS 
